Pathology · Neoplasia (Classification, Carcinogenesis, Tumor Markers, Paraneoplastic)

Promoter hypermethylation of RASSF1A gene in a non-small cell lung carcinoma silences a tumor suppressor that normally inhibits which oncogenic pathway?

  • A PI3K-AKT-mTOR signaling
  • B Ras-RAF-MAPK signaling
  • C Notch-Hes1 signaling
  • D Hedgehog-Gli signaling
Correct answer: B. Ras-RAF-MAPK signaling

Explanation

RASSF1A (Ras association domain family 1A) is a Ras effector protein that sequesters active Ras and prevents downstream RAF-MAPK activation; its promoter hypermethylation is one of the most frequent epigenetic silencing events in lung, breast, and other carcinomas. Loss of RASSF1A allows unopposed Ras-RAF-MEK-ERK signaling, promoting proliferation and survival. RASSF1A also interacts with microtubules and promotes apoptosis through MST1/2 kinases.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Neoplasia (Classification, Carcinogenesis, Tumor Markers, Paraneoplastic) MCQs

See all Neoplasia (Classification, Carcinogenesis, Tumor Markers, Paraneoplastic) MCQs →